


Coolspa by Aethos operates as a specialized aesthetic and medical wellness center in New York, NY, combining non-invasive body contouring with peptide-based weight management protocols. Established in 2010, the clinic has built its reputation around CoolSculpting procedures while expanding into functional medicine approaches that address metabolic health and body composition through pharmaceutical-grade peptide therapies. The Manhattan location serves patients seeking alternatives to surgical intervention for both aesthetic enhancement and clinically significant weight reduction.
The clinic's peptide therapy program centers on two FDA-approved GLP-1 receptor agonists: semaglutide and tirzepatide. Semaglutide works by mimicking the glucagon-like peptide-1 hormone to regulate appetite and insulin secretion, typically prescribed in weekly subcutaneous injections with dosing protocols adjusted based on patient response and tolerance. Tirzepatide functions as a dual GIP/GLP-1 receptor agonist, targeting both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 pathways for enhanced metabolic effects. These peptide protocols integrate with the clinic's body sculpting services, allowing patients to address weight loss systemically while targeting stubborn fat deposits through cryolipolysis. The facial rejuvenation services complement these treatments with injectable neuromodulators and dermal fillers administered to address volume loss that may occur during significant weight reduction.
Coolspa by Aethos requires in-person consultations for all peptide therapy candidates, conducting comprehensive metabolic assessments that include body composition analysis, medical history review, and evaluation of contraindications before initiating treatment. The clinical team develops individualized dosing schedules and monitors patients through regular follow-up appointments to adjust protocols based on weight loss velocity, side effect profiles, and metabolic markers. This hands-on approach distinguishes the practice from telehealth-only providers, particularly for New York residents who value direct access to clinical staff and same-location availability for both peptide management and complementary aesthetic procedures.
Patients beginning peptide therapy at the clinic undergo initial education sessions covering injection technique, medication storage requirements, expected timelines for appetite suppression and weight changes, and management of common gastrointestinal side effects associated with GLP-1 agonists. The treatment experience typically involves weekly or bi-weekly visits during the titration phase, transitioning to monthly monitoring once therapeutic dosing is established. The clinic's 4.9-star rating across 124 Google reviews reflects patient feedback on appointment availability, provider communication regarding realistic expectations, and coordination between weight management and body contouring treatment plans. The practice maintains evening and weekend appointment slots to accommodate working professionals in the New York metropolitan area.
Coolspa by Aethos differentiates itself through the integration model that combines peptide therapy with established aesthetic procedures rather than operating as a standalone weight loss clinic. Patients can schedule CoolSculpting sessions to address areas resistant to diet and medication-induced fat loss, receive facial injectables to maintain volume during weight reduction, and access ongoing peptide management within a single practice location. This consolidated approach appeals to patients seeking comprehensive body transformation protocols supervised by providers familiar with both metabolic medicine and aesthetic outcomes. The clinic does not offer virtual consultations or remote peptide prescribing, positioning itself for patients who prioritize in-office clinical relationships and live within commuting distance of the New York City location.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


